08189.HK
Tianjin TEDA Biomedical Engineering Company Limited
HKSE · Basic Materials · Agricultural Inputs · CN
HKD 0.25
+2.04%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 846.6M | 509.4M | 385.5M | 398.0M | 403.7M |
| Cost of Revenue | 806.7M | 474.7M | 368.5M | 376.6M | 433.3M |
| Gross Profit | 60.9M | 34.8M | 17.0M | 21.4M | 14.8M |
| Operating Expenses | |||||
| R&D Expense | 19.2M | 4.0M | 1.1M | 1.3M | 1.1M |
| SG&A Expense | 52.4M | 32.2M | 34.3M | 29.9M | 37.5M |
| General & Admin Expense | 19.8M | 23.0M | 20.3M | 21.8M | 27.0M |
| Selling & Marketing Expense | 4.6M | 9.2M | 13.9M | 8.1M | 10.5M |
| Other Expenses | (4.1M) | 22.1M | 10.0M | (24.4K) | (114.4K) |
| Total Operating Expenses | 67.5M | 58.3M | 45.4M | 31.2M | 38.5M |
| Cost and Expenses | 874.2M | 533.0M | 413.9M | 407.8M | 428.1M |
| Operating Income (EBIT) | (27.6M) | (23.6M) | (28.4M) | (9.8M) | (24.4M) |
| Non-Operating | |||||
| Interest Income | — | 75.6K | 48.0K | 250.0K | 762.8K |
| Interest Expense | 4.2M | 3.7M | 4.6M | 5.2M | 6.4M |
| Net Interest Income | (4.1M) | (3.6M) | (4.5M) | (4.9M) | (5.6M) |
| Other Non-Op Income/Expense | (116.4M) | (86.4M) | (9.8M) | (2.2M) | 359.3K |
| Non-Operating Income (excl Interest) | — | — | 18.5M | (3.0M) | — |
| EBT (Pre-Tax Income) | (144.0M) | (110.0M) | (38.2M) | (12.0M) | (24.1M) |
| Income Tax Expense | 1.3M | 593.3K | (221.3K) | (1.0M) | (507.1K) |
| Bottom Line | |||||
| Net Income | (118.3M) | (88.5M) | (27.8M) | (20.2M) | (27.5M) |
| Earnings from Cont. Ops | (145.4M) | (110.6M) | (38.0M) | (11.0M) | (23.5M) |
| Earnings from Discont. Ops | — | — | 1.8M | (5.6M) | (2.4M) |
| Bottom Line Net Income | (118.3M) | (88.5M) | (29.6M) | (14.6M) | (25.0M) |
| Per Share | |||||
| Basic EPS | (HK$0.01) | (HK$0.04) | (HK$0.02) | (HK$0.01) | (HK$0.01) |
| Diluted EPS | (HK$0.01) | (HK$0.04) | (HK$0.02) | (HK$0.01) | (HK$0.01) |
| Revenue Per Share | HK$3.97 | HK$0.24 | HK$0.22 | HK$0.21 | HK$0.21 |
| Shares | |||||
| Basic Shares Outstanding | 213.4M | 2.1B | 1.8B | 1.9B | 1.9B |
| Diluted Shares Outstanding | 213.4M | 2.1B | 1.9B | 1.9B | 1.9B |
| Profitability Metrics | |||||
| EBITDA | (24.2M) | (14.3M) | (20.2M) | 4.8M | (2.3M) |
| D&A | 3.5M | 9.2M | 8.2M | 11.6M | 15.4M |
| EBIT | (27.6M) | (23.6M) | (28.4M) | (6.8M) | (17.7M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026